Granata Guido, Manissero Davide, Oppia Maria Vittoria, Tone Keiko, Cai Bin, Longshaw Christopher, Venditti Carolina, Petrosillo Nicola
Severe and Immunocompromised-associated Infection Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Scientific Institute for Treatment and Inpatient Care, Rome, Italy.
Shionogi B.V., London, UK.
Infect Dis Rep. 2020 Aug 5;12(2):8510. doi: 10.4081/idr.2020.8510. eCollection 2020 May 29.
There is a lack of consensus regarding management of infections with carbapenem- resistant Gram-negative (CR-GN) pathogens. This study comprised a medical chart review to assess patient management in a high CR prevalence setting. Data was collated retrospectively from medical records of patients hospitalized between November 1, 2015 and October 31, 2016. Of 29 patients, 66% had respiratory tract infections. Median duration of hospitalization was 28 days and ~50% of patients were admitted to the intensive care unit, with 77% remaining for >2 weeks. Median time to obtain respiratory culture results was 5 days. Isolation of patients with diagnosed CR-GN infection took ≥5 days in >50% of patients. A majority (76%) of patients received ≥1 antibiotic before providing a specimen for culture; a total of 17 antibiotic treatments were used. Overall, 72% of patients, and 68% of those with respiratory infections, were discharged alive; 38% were discharged without further antibiotics. The difficulties in achieving effective management in patients with CR-GN infections are largely due to complex co-morbidities, a history of prior antibiotic treatment, and multiple referrals across health care facilities.
对于耐碳青霉烯类革兰氏阴性(CR - GN)病原体感染的管理,目前尚无共识。本研究包括对病历的回顾,以评估在CR高流行环境中的患者管理情况。数据是从2015年11月1日至2016年10月31日期间住院患者的病历中回顾性整理的。29名患者中,66%患有呼吸道感染。住院时间中位数为28天,约50%的患者入住重症监护病房,77%的患者住院时间超过2周。获得呼吸道培养结果的中位时间为5天。超过50%的确诊CR - GN感染患者隔离时间≥5天。大多数(76%)患者在提供培养标本前接受了≥1种抗生素治疗;总共使用了17种抗生素治疗。总体而言,72%的患者以及68%的呼吸道感染患者存活出院;38%的患者出院时未再使用抗生素。CR - GN感染患者难以实现有效管理,主要是由于复杂的合并症、既往抗生素治疗史以及跨医疗机构的多次转诊。